Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey

Altieri, 2022, The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: a meta-analysis, Mult. Scler. Relat. Disord., 61, 10.1016/j.msard.2022.103774 Boeschoten, 2017, Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis, J. Neurol. Sci., 372, 331, 10.1016/j.jns.2016.11.067 Chen, 2022, Healthcare disruptions and use of telehealth services among people with Multiple Sclerosis during the Covid-19 pandemic, Arch. Phys. Med. Rehabil., 103, 1379, 10.1016/j.apmr.2021.12.028 Chertcoff, 2021, Changes on the health care of people with multiple sclerosis from Latin America during the Covid-19 pandemic, Mult. Scler. Relat. Disord., 54, 10.1016/j.msard.2021.103120 Corea, 2021, Telemedicine during the Coronavirus Disease (Covid-19) pandemic: a Multiple Sclerosis (MS) outpatients service perspective, Neurol. Int., 13, 25, 10.3390/neurolint13010003 Costello, 2008, Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term, MedGenMed Medscape Gen. Med., 10, 225. García-Azorín, 2021, Disruptions of neurological services, its causes and mitigation strategies during Covid-19: a global review, J. Neurol., 268, 3947, 10.1007/s00415-021-10588-5 Goyal, 2021, Restricted access to the NHS during the Covid-19 pandemic: is it time to move away from the rationed clinical response?, Lancet Reg. Health Eur., 8 Hatcher-Martin, 2020, Telemedicine in neurology: telemedicine work group of the American academy of neurology update, Neurology, 94, 30, 10.1212/WNL.0000000000008708 Hatcher-Martin, 2021, American academy of neurology telehealth position statement, Neurology, 97, 334, 10.1212/WNL.0000000000012185 Keszler, 2021, Telemedicine utilization and perceptions of Multiple Sclerosis health care providers, Mult. Scler. J., 27, 96 Landi, 2022, Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey, Neurol. Sci., 43, 1197, 10.1007/s10072-021-05398-6 Landtblom, 2021, Multiple sclerosis and Covid-19: the Swedish experience, Acta Neurol. Scand., 144, 229, 10.1111/ane.13453 Landtblom, 2019, RebiQoL: a randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif, PLOS One, 14, 10.1371/journal.pone.0218453 McGinley, 2021, Expanded access to Multiple Sclerosis teleneurology care following the Covid-19 pandemic, Mult. Scler. J. Exp. Transl. Clin., 7 Morrison, 2021, How the Covid-19 Pandemic has changed Multiple Sclerosis clinical practice: results of a nationwide provider survey, Mult. Scler. Relat. Disord., 51, 10.1016/j.msard.2021.102913 Moss, 2020, Multiple Sclerosis management during the Covid-19 pandemic, Mult. Scler., 26, 1163, 10.1177/1352458520948231 Portaccio, 2022, Impact of Covid-19 on Multiple Sclerosis care and management: results from the European Committee for treatment and research in Multiple Sclerosis survey, Mult. Scler., 28, 132, 10.1177/13524585211005339 Rieckmann, 2015, Achieving patient engagement in multiple sclerosis: a perspective from the multiple sclerosis in the 21st century steering group, Mult. Scler. Relat. Disord., 4, 202, 10.1016/j.msard.2015.02.005 Rintell, 2012, Patients’ perspectives on quality of mental health care for people with MS, Gen. Hosp. Psychiatry, 34, 604, 10.1016/j.genhosppsych.2012.04.001 Simpson-Yap, 2021, Associations of disease-modifying therapies with Covid-19 severity in Multiple Sclerosis, Neurology, 97, e1870, 10.1212/WNL.0000000000012753 Spadea, 2021, Indirect impact of Covid-19 on hospital care pathways in Italy, Sci. Rep., 11, 21526, 10.1038/s41598-021-00982-4 WHO Director-General's opening remarks at the media briefing on Covid-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–11-march-2020. Accessed 29 Jun 2022.